Association of maternal viral load and CD4 count with perinatal HIV-1 transmission risk during breastfeeding in the PROMISE postpartum component
Journal of Acquired Immune Deficiency Syndromes Sep 20, 2021
Flynn PM, Taha TE, Cababasay M, et al. - On assessing the correlation of maternal viral load (MVL) and CD4 cell counts with breastfeeding HIV transmission, researchers identified that risk of infant HIV-1 infection is increased in women receiving mART, increased MVL and decreased CD4 cell counts during breastfeeding.
Randomized were breastfeeding mothers with HIV infection who did not qualify for antiretroviral therapy (ART) based on country-specific guidelines at the time of the Promoting Maternal-Infant Survival Everywhere trial and their uninfected neonates to either maternal ART (mART) or infant nevirapine prophylaxis (iNVP) postpartum.
The two arms had similar proportions of HIV transmission (< 1%). Enrolled were 2,431 mother–infant pairs.
No significant association of baseline MVL and CD4 cell counts was observed with infant HIV-1 infection.
In the mART arm, significant association of time-varying MVL, as well as of time-varying CD4 cell counts, was observed with infant HIV-1 infection.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries